NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









PBS Biotech

PBS Biotech

Private
Camarillo, CaliforniaHealthcare & Life Scienceshttps://pbsbiotech.com/

Last Round

Growth Equity

Jan 6, 2025

Est. Valuation

$224.5M

Total Funding Raised

$49M

Company Overview

PBS Biotech is a biotechnology company that manufactures single-use bioreactor systems and provides process development services for the cell therapy industry.

Sector

Healthcare & Life Sciences

Verticals

Biotech Equipment, Biotechnology

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Non-AI

Keywords

single-use bioreactorVertical-Wheel technologycell therapy manufacturingbioprocessinglow-shear bioreactorcell therapy scale-upprocess development servicesCDMO servicesallogeneic cell therapybioreactor consumablescell and gene therapyiPSC cultureMSC culturebiotech equipmentCAR-T

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

PBS Biotech Comparables

Compare PBS Biotech with similar companies based on industry and business-model similarity.

PBS Biotech comparables — related companies by embedding similarity
CompanySimilarityMarket Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

PBS Biotech Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Growth EquityJan 6, 2025
VC RoundSep 11, 2024
Series BJan 9, 2023
Series AAug 16, 2021
View all Funding Rounds

Key People

Founding team and executive leadership

Brian Lee

Founder & Chief Technology Officer, Chief Executive Officer

Founding Team

Martin Simonetti

Chief Executive Officer

Executive Team

Erik Wiberg

Chief Financial Officer

Executive Team

PBS Biotech Investors

Notable investors and investment history

PBS Biotech investors
InvestorRounds
Avego ManagementGrowth Equity, VC Round, Series B
BroadOak Capital PartnersGrowth Equity, VC Round, Series B, Series A
View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 26, 2026

    Monthly visitors grew 101% MoM.

  • May 4, 2025

    Monthly visitors increased 68% MoM, reaching 3.2K.

View all signals

PBS Biotech Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

PBS Biotech Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about PBS Biotech's valuation, stock price, and market status.

Firmographic Details

HeadquartersCamarillo, California
Employee Range103
Year Founded2006
Last FundingJan 6, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.